Advertisement
ANGO vs STRRP
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANGO is a Buy and STRRP is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANGO’s FA Score shows that 0 FA rating(s) are green whileSTRRP’s FA Score has 1 green FA rating(s).
- ANGO’s FA Score: 0 green, 5 red.
- STRRP’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANGO’s TA Score shows that 5 TA indicator(s) are bullish while STRRP’s TA Score has 6 bullish TA indicator(s).
- ANGO’s TA Score: 5 bullish, 4 bearish.
- STRRP’s TA Score: 6 bullish, 2 bearish.
Price Growth
ANGO (@Pharmaceuticals: Other) experienced а +8.83% price change this week, while STRRP (@Other Consumer Services) price change was +1.41% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +5.03%. For the same industry, the average monthly price growth was +0.09%, and the average quarterly price growth was -1.71%.
The average weekly price growth across all stocks in the @Other Consumer Services industry was -1.01%. For the same industry, the average monthly price growth was -1.75%, and the average quarterly price growth was +7.81%.
Reported Earning Dates
ANGO is expected to report earnings on Oct 01, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+5.03% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Other Consumer Services (-1.01% weekly)Other consumer services include companies that provide consumer services, and are not classified elsewhere. Travel fare aggregators, hotel bookings, consumer-to-consumer or business-to-business sales platforms are some examples of services that can be clubbed into this category. Many of such services have expanded online. Booking Holdings Inc, The Priceline Group Inc, and eBay Inc. are some major operators in this segment.
| ANGO | STRRP | ANGO / STRRP | |
| Capitalization | 611M | N/A | - |
| EBITDA | 626K | -3.24M | -19% |
| Gain YTD | 15.187 | 13.473 | 113% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 320M | 190M | 168% |
| Total Cash | 53.9M | 12.2M | 442% |
| Total Debt | 5M | 26.7M | 19% |
ANGO | STRRP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 35 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 58 Fair valued | 2 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 87 | |
SMR RATING 1..100 | 97 | 100 | |
PRICE GROWTH RATING 1..100 | 37 | 48 | |
P/E GROWTH RATING 1..100 | 56 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
STRRP's Valuation (2) in the null industry is somewhat better than the same rating for ANGO (58) in the Medical Specialties industry. This means that STRRP’s stock grew somewhat faster than ANGO’s over the last 12 months.
STRRP's Profit vs Risk Rating (87) in the null industry is in the same range as ANGO (100) in the Medical Specialties industry. This means that STRRP’s stock grew similarly to ANGO’s over the last 12 months.
ANGO's SMR Rating (97) in the Medical Specialties industry is in the same range as STRRP (100) in the null industry. This means that ANGO’s stock grew similarly to STRRP’s over the last 12 months.
ANGO's Price Growth Rating (37) in the Medical Specialties industry is in the same range as STRRP (48) in the null industry. This means that ANGO’s stock grew similarly to STRRP’s over the last 12 months.
ANGO's P/E Growth Rating (56) in the Medical Specialties industry is somewhat better than the same rating for STRRP (100) in the null industry. This means that ANGO’s stock grew somewhat faster than STRRP’s over the last 12 months.
| ANGO | STRRP | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 78% | N/A |
| Stochastic ODDS (%) | 3 days ago 82% | 3 days ago 37% |
| Momentum ODDS (%) | 3 days ago 73% | 3 days ago 44% |
| MACD ODDS (%) | 3 days ago 84% | 3 days ago 54% |
| TrendWeek ODDS (%) | 3 days ago 77% | 3 days ago 40% |
| TrendMonth ODDS (%) | 3 days ago 71% | 3 days ago 42% |
| Advances ODDS (%) | 3 days ago 75% | 5 days ago 44% |
| Declines ODDS (%) | 11 days ago 71% | 10 days ago 31% |
| BollingerBands ODDS (%) | 3 days ago 80% | N/A |
| Aroon ODDS (%) | 3 days ago 67% | 3 days ago 49% |
Advertisement